Vivos Therapeutics (VVOS) Net Cash Flow (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos Therapeutics | 9.87 Mn | 7.64 Mn | 3.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108.03% |
| Dec 31, 2025 | 25.48% |
| Sep 30, 2025 | 85.61% |
| Jun 30, 2025 | -140.17% |
| Mar 31, 2025 | -35,518.18% |
| Dec 31, 2024 | 98.18% |
| Sep 30, 2024 | -114.27% |
| Jun 30, 2024 | 330.89% |
| Mar 31, 2024 | 39.97% |
| Dec 31, 2023 | 123.78% |
| Sep 30, 2023 | 4.77% |
| Jun 30, 2023 | -188.01% |
| Mar 31, 2023 | 210.22% |
| Dec 31, 2022 | 46.67% |
| Sep 30, 2022 | -17.55% |
| Jun 30, 2022 | 17.94% |
| Mar 31, 2022 | -38.10% |
| Dec 31, 2021 | 20.48% |
| Sep 30, 2021 | -128.07% |
| Jun 30, 2021 | 581.94% |
| Mar 31, 2021 | -125.17% |
| Dec 31, 2020 | 1,363.80% |
| Sep 30, 2020 | 270.36% |
| Jun 30, 2020 | 184.63% |